161 results for “Merck”
| Medicine | Active substance | Licence holder | Status |
|---|
| Velmetia 50 mg/1000 mg film-coated tablets EU/1/08/456/8-14 |
Sitagliptin phosphate, Metformin Hydrochloride |
Merck Sharp & Dohme BV |
— |
| Velmetia 50 mg/850 mg film-coated tablets EU/1/08/456/1-7 |
Sitagliptin phosphate, Metformin Hydrochloride |
Merck Sharp & Dohme BV, |
— |
| WELIREG 40 mg film-coated tablets EU/1/24/1893/001-002 |
Belzutifan |
Merck Sharp & Dohme BV, |
— |
| Winrevair 45 mg powder and solvent for solution for injection EU/1/24/1850/001-002 |
Sotatercept |
Merck Sharp & Dohme BV, |
— |
| Winrevair 60 mg powder and solvent for solution for injection EU/1/24/1850/003-004 |
Sotatercept |
Merck Sharp & Dohme BV, |
— |
| Xelevia 100 mg film-coated tablets EU/1/07/382/13-18 |
Sitagliptin phosphate monohydrate |
Merck Sharp & Dohme BV |
— |
| Xelevia 25 mg film-coated tablets EU/1/07/382/1-6 |
Sitagliptin phosphate monohydrate |
Merck Sharp & Dohme BV |
— |
| Xelevia 50 mg film-coated tablets EU/1/07/382/7-12 |
Sitagliptin phosphate monohydrate |
Merck Sharp & Dohme BV |
— |
| ZEPATIER 50 mg/100 mg film-coated tablets EU/1/16/1119/001 |
Grazoprevir, Elbasvir |
Merck Sharp & Dohme BV, |
— |
| Zerbaxa 1 g/0.5 g powder for concentrate for solution for infusion EU/1/15/1032/001 |
Ceftolozane sulfate, Tazobactam sodium |
Merck Sharp & Dohme BV, |
— |
| ZINPLAVA 25 mg/mL concentrate for solution for infusion EU/1/16/1156/001 |
Bezlotoxumab |
Merck Sharp & Dohme BV |
— |
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.